These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 12127892)
41. Pediatric research: what is broken and what needs to be fixed? Lantos JD J Pediatr; 2004 Feb; 144(2):147-9. PubMed ID: 14760250 [No Abstract] [Full Text] [Related]
42. Maryland Court ruling sets precedent on research involving minors. Grimes v. Kennedy Krieger Institute, Inc. Roeder KH; Martin SH; Rees JS GHA Today; 2001 Oct; 45(9):3, 8. PubMed ID: 11715756 [No Abstract] [Full Text] [Related]
43. [Children as research subjects--have we exceeded one or two principles?]. Bratlid D Tidsskr Nor Laegeforen; 2004 Feb; 124(4):510-2. PubMed ID: 14983202 [No Abstract] [Full Text] [Related]
44. Secret human experiments test trust in government. Guttman D Forum Appl Res Public Policy; 1997; 12(3):109-14. PubMed ID: 12962097 [No Abstract] [Full Text] [Related]
45. Medical studies and the average American kid. Weiss R Washington Post; 2005 Aug; ():A5. PubMed ID: 16138447 [No Abstract] [Full Text] [Related]
46. Preventing childhood lead poisoning in Tennessee. Yarbrough M; Holmes M Tenn Med; 1996 Nov; 89(11):415-6, 418. PubMed ID: 8942281 [No Abstract] [Full Text] [Related]
47. Author response to letter regarding "Children in clinical research: a conflict of moral values" (AJOB 3:1). Sharav VH Am J Bioeth; 2004; 4(3):W35-7. PubMed ID: 16192118 [No Abstract] [Full Text] [Related]
48. Pica and lead poisoning. Guinee VF Nutr Rev; 1971 Dec; 29(12):267-9. PubMed ID: 5127163 [No Abstract] [Full Text] [Related]
49. Medical testing: issues and ethics. Mossman KL Forum Appl Res Public Policy; 1997; 12(3):90-101. PubMed ID: 12962094 [No Abstract] [Full Text] [Related]
50. The public health problems of lead exposure. Bell A Med J Aust; 1994 Jul; 161(2):175. PubMed ID: 8028553 [No Abstract] [Full Text] [Related]
51. Commentary on the EMA Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products. van Gerven J; Bonelli M Br J Clin Pharmacol; 2018 Jul; 84(7):1401-1409. PubMed ID: 29451320 [No Abstract] [Full Text] [Related]
52. Ethically questionable research with children: the fenfluramine study. Shamoo AE; Tauer CA Account Res; 2002; 9(3-4):143-66. PubMed ID: 12816124 [No Abstract] [Full Text] [Related]
53. Two health problems: one solution. McLaughlin MC Bull N Y Acad Med; 1970 Jun; 46(6):454-6. PubMed ID: 5267237 [No Abstract] [Full Text] [Related]
54. Lead-poisoning prevention in Massachusetts. N Engl J Med; 1973 Aug; 289(8):428-9. PubMed ID: 4740518 [No Abstract] [Full Text] [Related]
57. Worker lead poisoning during renovation of a historic hotel reveals limitations of the OSHA lead in construction standard. Zhu J; Franko E; Pavelchak N; DePersis R J Occup Environ Hyg; 2012; 9(9):D167-71. PubMed ID: 22827805 [No Abstract] [Full Text] [Related]
58. Informed consent and medical experimentation. Martin GH Iustitia; 1975; 3(1):29-58. PubMed ID: 11665229 [No Abstract] [Full Text] [Related]
59. Lead poisoning prevention, not chelation (commentary). Henretig F J Toxicol Clin Toxicol; 2001; 39(7):659-60. PubMed ID: 11778662 [No Abstract] [Full Text] [Related]
60. Maximum daily intake of lead without excessive body lead-burden in children. King BG Am J Dis Child; 1971 Oct; 122(4):337-40. PubMed ID: 5115530 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]